MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Triple Helix _ Translation, Commercialization, Technology Transfer, SBIR/STTR, OTA, NonTraditional / New Business Models
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Northern California & Silicon Valley
Codexis, Inc. (NASDAQ: CDXS)
Organization & Developments: Codexis
Parents
Codexis, Inc. (NASDAQ: CDXS)
Children
2020: A New Way Of Making DNA Is About To Revolutionize The Biotech Industry
2020: Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
2022: Enzyme engineer Codexis cuts short several programs, lays off 18% of staff
Advantages of its process:
Codexis (NASDAQ: CDXS) made headlines back in April 2010 when it went public at $13 a share
Enzyme technology and its potential use for the future of renewable biofuels.
Make active pharmaceutical ingredient for drugmakers
Molecular Breeding
New Catalysts that Break down Cellulosic Biomass Sugarcane into Renewable Fuel
Or Concentrate Carbon Dioxide so It Can Be Stashed Underground to Limit the Pollution from Coal-fired Power Plants.
Rapidly generate novel biological catalysts
Scientists take an existing enzyme, or stretch of DNA to make an enzyme, and tweak properties here and there to get a useful pro
Spinoff from Maxygen, which itself spun off from Affymax.
The underlying technology is all about what’s known as “directed evolution,”
What fewer people realize is that while this is largely about technology, Codexis is on pace to generate almost $100 million in
Jumps
*Key People: Codexis
Finance & Acquisitions: Codexis